Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-reactive protein levels following hepatitis B vaccine in full-term neonates
TCTR20200930001Recruiting
- Sponsor
- Mahidol University
- Start
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Mahidol University. Primary endpoint: C-reactive protein level after hepatitis B vaccination. Started Aug 2020; status: recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on TCTR20200930001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200930001.